|
시장보고서
상품코드
2050617
로사르탄 시장 : 적응증별, 용량별, 제품 유형별, 연령층별, 성별, 유통 채널별, 제형별, 공급원별, 지역별Losartan Market, By indication, By Strength, By Product Type, By Age Group, By Gender, By Distribution Channel, By Form, By Source, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
로사르탄 시장은 2026년에 17억 5,000만 달러로 추정되고 있으며, 2033년에 23억 5,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 4.3%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 17억 5,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 4.30% | 2033년 시장 규모 예측 : | 23억 5,000만 달러 |
전 세계 고혈압 및 심혈관 질환의 유병률 증가를 배경으로 세계 로사르탄 시장은 최근 수년간 괄목할 만한 성장세를 보이고 있습니다. 안지오텐신 II 수용체 길항제인 로살탄은 고혈압, 심부전, 당뇨병성 신증 치료제로 널리 사용되고 있습니다. 시장 확대는 건강에 해로운 생활 습관과 효과적인 혈압 관리의 중요성에 대한 인식이 높아짐에 따라 더욱 가속화되고 있습니다. 또한 로살탄의 제네릭 의약품의 보급으로 접근성과 경제성이 향상되어 폭넓은 채택에 기여하고 있습니다. 효과적인 강압제에 대한 수요가 지속적으로 증가함에 따라 글로벌 로살탄 시장은 향후 수년간 큰 폭의 성장이 예상됩니다.
시장 역학
세계의 로사르탄 시장은 몇 가지 주요 촉진요인, 제약 조건 및 기회에 의해 영향을 받습니다. 시장 성장의 주요 촉진요인은 고혈압과 심부전 및 뇌졸중과 같은 심혈관 질환의 유병률 증가입니다. 좌식 생활, 비만, 높은 스트레스 등 건강에 해로운 생활습관이 고혈압 발병률을 크게 증가시키고 있습니다. 또한 효과적인 혈압 관리의 중요성에 대한 인식이 높아지고 저렴한 가격의 로살탄 복제약의 보급이 시장 성장을 촉진하고 있습니다. 그러나 시장에는 대체할 수 있는 강압제의 존재와 로살탄 사용에 따른 잠재적 부작용 등 몇 가지 제약이 존재합니다. 또한 브랜드 제품인 로사르탄 제품의 특허만료로 제네릭 업체와의 경쟁이 심화되고 있으며, 주요 업체들의 시장점유율에 영향을 미칠 수 있습니다. 이러한 어려움에도 불구하고 새로운 약물전달 시스템 개발, 로살탄의 치료 적응증 확대, 고혈압 유병률이 높은 신흥 국가에서의 미개발된 잠재적 수요 등 유망한 성장 기회가 존재합니다. 또한 제약사 간의 전략적 제휴와 합병이 향후 수년간 혁신을 촉진하고 시장 범위를 확대할 것으로 예상됩니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 로사르탄 시장의 주요 기업을 프로파일링합니다. 기업 하이라이트,제품 포트폴리오,주요 하이라이트,재무 성과,전략
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계의 로사르탄 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 로사르탄 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 로사르탄 시장 : 적응증별, 2021-2033년
제5장 세계의 로사르탄 시장 : 용량별, 2021-2033년
제6장 세계의 로사르탄 시장 : 제품 유형별, 2021-2033년
제7장 세계의 로사르탄 시장 : 연령층별, 2021-2033년
제8장 세계의 로사르탄 시장 : 성별, 2021-2033년
제9장 세계의 로사르탄 시장 : 유통 채널별, 2021-2033년
제10장 세계의 로사르탄 시장 : 형태별, 2021-2033년
제11장 세계의 로사르탄 시장 : 공급원별, 2021-2033년
제12장 세계의 로사르탄 시장 : 지역별, 2021-2033년
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고 문헌과 조사 방법
KSA 26.06.10Losartan Market is estimated to be valued at USD 1.75 Bn in 2026 and is expected to reach USD 2.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.75 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.30% | 2033 Value Projection: | USD 2.35 Bn |
The global Losartan market has witnessed significant growth in recent years, driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Losartan, an angiotensin II receptor antagonist, is widely prescribed for the treatment of high blood pressure, heart failure, and diabetic nephropathy. The market's expansion is further fueled by unhealthy lifestyles and rising awareness about the importance of effective blood pressure management. Moreover, the availability of generic Losartan products has increased their accessibility and affordability, contributing to their widespread adoption. As the demand for efficient antihypertensive medications continues to rise, the global Losartan market is poised for substantial growth in the coming years.
Market Dynamics
The global Losartan market is influenced by several key drivers, restraints, and opportunities. The primary driver for market growth is the increasing prevalence of hypertension and related cardiovascular disorders, such as heart failure and stroke. Unhealthy lifestyles characterized by sedentary behavior, obesity, and high-stress levels have led to a significant increase in the incidence of hypertension. Furthermore, the growing awareness about the importance of effective blood pressure management and the availability of affordable generic Losartan products have boosted the market's growth. However, the market also faces certain restraints, such as the presence of alternative antihypertensive medications and potential side effects associated with Losartan use. Additionally, the expiration of patents for branded Losartan products has led to increased competition from generic manufacturers, potentially impacting the market share of key players. Despite these challenges, the market presents promising opportunities for growth, including the development of novel drug delivery systems, the expansion of Losartan's therapeutic applications, and the untapped potential in emerging economies with high hypertension prevalence rates. Moreover, strategic collaborations and mergers among pharmaceutical companies are expected to drive innovation and expand market reach in the coming years.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global Losartan market based on the following parameters: company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Mylan N.V., Organon LLC, Alembic Pharmaceuticals Ltd, Macleods Pharmaceuticals Ltd, Teva Pharmaceuticals Usa, Aurobindo Pharma, Lupin Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Alkem Laboratories, Granules India Ltd, and Micro Labs Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global Losartan market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Losartan market.
Market Segmentation
- Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Hypertension
- Left Ventricular Hypertrophy (LVH)
- Diabetic Nephropathy
- Others (Stroke, etc.)
- Strength Insights (Revenue, USD Bn, 2021 - 2033)
- 5 mg
- 25 mg
- 50 mg
- 100 mg
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Branded
- Generic
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Form Insights (Revenue, USD Bn, 2021 - 2033)
- Tablet
- Powder
- Suspension
- Source Insights (Revenue, USD Bn, 2021 - 2033)
- Contract Manufacturing Organizations
- In-House Manufacturing
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U,S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd
- Mylan N.V.
- Organon LLC
- Alembic Pharmaceuticals Ltd
- Macleods Pharmaceuticals Ltd
- Teva Pharmaceuticals USA
- Aurobindo Pharma
- Lupin Limited
- Reddy's Laboratories
- Sun Pharmaceutical Industries Ltd
- Zydus Cadila
- Torrent Pharmaceuticals Ltd
- Cipla Ltd
- Glenmark Pharmaceuticals
- Alkem Laboratories
- Granules India Ltd
- Micro Labs Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Losartan Market, By Indication
- Global Losartan Market, By Strength
- Global Losartan Market, By Product Type
- Global Losartan Market, By Age Group
- Global Losartan Market, By Gender
- Global Losartan Market, By Distribution Channel
- Global Losartan Market, By Form
- Global Losartan Market, By Source
- Global Losartan Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
- Treatment Option Analysis
- Drug Resistance Scenario
- Reimbursement Scenario
- Regulatory Scenario
4. Global Losartan Market, By Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Left Ventricular Hypertrophy (LVH)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diabetic Nephropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Stroke, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Losartan Market, By Strength, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 5 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 25 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- 100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Losartan Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Losartan Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Losartan Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Losartan Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Losartan Market, By Form, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Losartan Market, By Source, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- In-House Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Losartan Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Source, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organon LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alembic Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Macleods Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals Usa
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lupin Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Torrent Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkem Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Granules India Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Micro Labs Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
